Product Information

METHYLPHENIDATE 20 MG/9 HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $7.1080 per EA under NDC 00378826293. Its NADAC has been published 162 times since Jul 19, 2023.

FDA first approved this application on Mar 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 20 MG/9 HR PATCH

Methylphenidate
$7.1080per EA
DEA Schedule CII

Strength

2.2 mg/h

NDC

00378826293

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

METHYLPHENIDATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206497

FDA Approved

3/14/2022

TE Code

AB

On Market Since

6/27/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 20 MG/9 HR PATCH has been published 162 times since Jul 19, 2023, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.

Current price$7.1080 per EA
All-time high$12.4843 (Mar 13, 2024)
All-time low$7.1080 (Aug 19, 2026)
52-week high$10.8599
52-week low$7.1080
Median price$9.7110
Average price$10.0440
Largest weekly change-9.1% (Mar 20, 2024)
Weeks tracked162
Tracking sinceJul 19, 2023

Price History

1W

-5.9%

1M

-5.9%

3M

-15.9%

6M

-21.4%

1Y

-30.4%

3Y

-38.2%

5Y

N/A

All

-38.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 20 MG/9 HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG/9 HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $7.1080 per EA (NDC 00378826293), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE 20 MG/9 HR PATCH changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG/9 HR PATCH has declined 38.2%. It has been tracked across 162 weekly CMS publications since Jul 19, 2023.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG/9 HR PATCH?

Since Jul 19, 2023, the NADAC for METHYLPHENIDATE 20 MG/9 HR PATCH has ranged from a low of $7.1080 (Aug 19, 2026) to a high of $12.4843 (Mar 13, 2024), with a median of $9.7110 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 20 MG/9 HR PATCH?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 20 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE 20 MG/9 HR PATCH?

METHYLPHENIDATE 20 MG/9 HR PATCH (NDC 00378826293) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.